After eleven months of negotiating, CRKN’s Content Strategy Committee (CSC) has achieved a renewal of the Elsevier ScienceDirect license, which includes:
- A 12.5% reduction for 2021, followed by a 0% change for 2022, and a 2% increase for 2023. The renewed agreement maintains access to all journals in the Freedom Collection, including former Academic Press journals, and members’ subscribed titles, with no loss of perpetual access rights. This results in cost savings of US$17.4 million over three years (when compared with a three-year contract with anticipated 2% annual increases).
- A 20% discount on Article Processing Charges (APCs) for both hybrid and gold open access journals. Cell Press, Lancet, and some other society-owned journals are excluded.
- No confidentiality or non-disclosure clause which ensures transparency and allows the terms to be shared.
The 2021-2023 CRKN-Elsevier ScienceDirect license includes 70 participants for a total contract value of US$95.5 million over three years. A public announcement regarding the renewal is available here.
CRKN gratefully acknowledges the support and collaboration of the Stakeholder Alignment Group, Content Strategy Committee, Elsevier negotiation CSC sub-group, and the entire CRKN membership throughout the negotiations for this license.
The license agreement is available for download here.